SIGN UP
LOG IN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·12/03/2024 21:05:50
Listen to the news
Gainers
- Janux Therapeutics (NASDAQ:JANX) shares moved upwards by 67.4% to $67.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.5 billion.
- Coherus BioSciences (NASDAQ:CHRS) shares rose 48.9% to $2.04. The company's market cap stands at $235.0 million.
- Citius Oncology (NASDAQ:CTOR) stock moved upwards by 22.54% to $1.25. The market value of their outstanding shares is at $89.1 million.
- Vir Biotechnology (NASDAQ:VIR) shares rose 21.47% to $9.9. The market value of their outstanding shares is at $1.3 billion.
- Kindly MD (NASDAQ:KDLY) shares rose 19.29% to $1.36. The company's market cap stands at $8.1 million.
- PepGen (NASDAQ:PEPG) stock rose 18.76% to $7.09. The company's market cap stands at $231.1 million.
Losers
- Purple Biotech (NASDAQ:PPBT) stock decreased by 27.7% to $6.07 during Tuesday's pre-market session. The market value of their outstanding shares is at $205.8 million.
- Gelteq (NASDAQ:GELS) shares decreased by 24.36% to $2.89. The market value of their outstanding shares is at $27.2 million.
- Sharps Technology (NASDAQ:STSS) stock decreased by 16.51% to $2.8. The company's market cap stands at $5.0 million.
- Revelation Biosciences (NASDAQ:REVB) stock declined by 14.73% to $0.81. The market value of their outstanding shares is at $3.4 million.
- InspireMD (NASDAQ:NSPR) shares fell 13.78% to $2.63. The company's market cap stands at $68.6 million.
- Aptorum Gr (NASDAQ:APM) shares fell 12.31% to $0.74. The company's market cap stands at $4.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.